Formation, Distribution, and Elimination of Infliximab and Anti-Infliximab Immune Complexes in Cynomolgus Monkeys-Reference-Cited by-同舟云学术

Formation, Distribution, and Elimination of Infliximab and Anti-Infliximab Immune Complexes in Cynomolgus Monkeys

Published:2005-01-12 Issue:2 Volume:313 Page:578-585
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Rojas Jeannie R.,Taylor Ronald P.,Cunningham Mark R.,Rutkoski Thomas J.,Vennarini Joseph,Jang Haishan,Graham Martin A.,Geboes Karel,Rousselle Serge D.,Wagner Carrie L.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference20 articles.

1. MECHANISMS OF PHAGOCYTOSIS IN MACROPHAGES

2. Fc receptors in liver sinusoidal endothelial cells in nzb/w fl lupus mice: a Histological analysis using soluble immunoglobulin g?immune complexes and a monoclonal antibody (2.4g2)

3. Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

4. Primate erythrocyte-immune complex-clearing mechanism.

5. Fc RECEPTOR BIOLOGY

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of positive controls and their impact on anti-drug antibody assay performance;Journal of Immunological Methods;2024-05

2. Biodistribution of Drug/ADA Complexes: The Impact of Immune Complex Formation on Antibody Distribution;The AAPS Journal;2024-03-13

3. ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse;Clinical Gastroenterology and Hepatology;2023-11

4. Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture;Journal of Controlled Release;2023-02

5. Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring;The Journal of Clinical Pharmacology;2022-12-29